nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CHRM2—type 1 diabetes mellitus	0.709	1	CbGaD
Paroxetine—TACR1—peripheral nervous system—type 1 diabetes mellitus	0.00739	0.165	CbGeAlD
Paroxetine—HTR2A—arteriole—type 1 diabetes mellitus	0.00583	0.13	CbGeAlD
Paroxetine—TACR1—nerve—type 1 diabetes mellitus	0.00576	0.128	CbGeAlD
Paroxetine—SLC6A2—autonomic nervous system—type 1 diabetes mellitus	0.00416	0.0926	CbGeAlD
Paroxetine—SLC6A3—nerve—type 1 diabetes mellitus	0.0029	0.0646	CbGeAlD
Paroxetine—Cerebrovascular disorder—Ramipril—type 1 diabetes mellitus	0.00288	0.0243	CcSEcCtD
Paroxetine—Cerebral ischaemia—Ramipril—type 1 diabetes mellitus	0.00267	0.0225	CcSEcCtD
Paroxetine—Kidney function abnormal—Ramipril—type 1 diabetes mellitus	0.00267	0.0225	CcSEcCtD
Paroxetine—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.00263	0.0221	CcSEcCtD
Paroxetine—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.0025	0.0557	CbGeAlD
Paroxetine—SLC6A2—nerve—type 1 diabetes mellitus	0.00234	0.0521	CbGeAlD
Paroxetine—Sleep disturbance—Ramipril—type 1 diabetes mellitus	0.0023	0.0194	CcSEcCtD
Paroxetine—Inappropriate antidiuretic hormone secretion—Ramipril—type 1 diabetes mellitus	0.00222	0.0187	CcSEcCtD
Paroxetine—Hepatic necrosis—Ramipril—type 1 diabetes mellitus	0.00222	0.0187	CcSEcCtD
Paroxetine—Parosmia—Ramipril—type 1 diabetes mellitus	0.00199	0.0167	CcSEcCtD
Paroxetine—Neuralgia—Ramipril—type 1 diabetes mellitus	0.00185	0.0156	CcSEcCtD
Paroxetine—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.0018	0.0402	CbGeAlD
Paroxetine—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.00173	0.0145	CcSEcCtD
Paroxetine—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.0016	0.0135	CcSEcCtD
Paroxetine—Ageusia—Ramipril—type 1 diabetes mellitus	0.00159	0.0134	CcSEcCtD
Paroxetine—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00155	0.0131	CcSEcCtD
Paroxetine—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00149	0.0125	CcSEcCtD
Paroxetine—Cough increased—Ramipril—type 1 diabetes mellitus	0.00141	0.0119	CcSEcCtD
Paroxetine—HTR2A—nerve—type 1 diabetes mellitus	0.00141	0.0313	CbGeAlD
Paroxetine—Glossitis—Ramipril—type 1 diabetes mellitus	0.0014	0.0118	CcSEcCtD
Paroxetine—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.00137	0.0115	CcSEcCtD
Paroxetine—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.00125	0.0105	CcSEcCtD
Paroxetine—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00122	0.0102	CcSEcCtD
Paroxetine—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00121	0.0102	CcSEcCtD
Paroxetine—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00117	0.00987	CcSEcCtD
Paroxetine—Urine output increased—Ramipril—type 1 diabetes mellitus	0.00117	0.00981	CcSEcCtD
Paroxetine—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00115	0.00971	CcSEcCtD
Paroxetine—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00108	0.0091	CcSEcCtD
Paroxetine—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00107	0.00897	CcSEcCtD
Paroxetine—Polyuria—Ramipril—type 1 diabetes mellitus	0.00107	0.00897	CcSEcCtD
Paroxetine—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.00106	0.00889	CcSEcCtD
Paroxetine—Deafness—Ramipril—type 1 diabetes mellitus	0.00105	0.00881	CcSEcCtD
Paroxetine—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00105	0.00881	CcSEcCtD
Paroxetine—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00104	0.00877	CcSEcCtD
Paroxetine—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.00104	0.00873	CcSEcCtD
Paroxetine—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.00102	0.0227	CbGeAlD
Paroxetine—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00101	0.00853	CcSEcCtD
Paroxetine—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00101	0.0085	CcSEcCtD
Paroxetine—Amnesia—Ramipril—type 1 diabetes mellitus	0.000996	0.00839	CcSEcCtD
Paroxetine—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.000991	0.00835	CcSEcCtD
Paroxetine—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.000987	0.00831	CcSEcCtD
Paroxetine—Renal impairment—Ramipril—type 1 diabetes mellitus	0.000983	0.00828	CcSEcCtD
Paroxetine—Purpura—Ramipril—type 1 diabetes mellitus	0.000971	0.00817	CcSEcCtD
Paroxetine—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.000967	0.00814	CcSEcCtD
Paroxetine—Arthritis—Ramipril—type 1 diabetes mellitus	0.000963	0.00811	CcSEcCtD
Paroxetine—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.000959	0.00807	CcSEcCtD
Paroxetine—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.000955	0.00804	CcSEcCtD
Paroxetine—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.000939	0.00791	CcSEcCtD
Paroxetine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.000928	0.00782	CcSEcCtD
Paroxetine—CHRM1—cardiovascular system—type 1 diabetes mellitus	0.000927	0.0207	CbGeAlD
Paroxetine—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.000864	0.00727	CcSEcCtD
Paroxetine—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.000854	0.0072	CcSEcCtD
Paroxetine—Breast disorder—Ramipril—type 1 diabetes mellitus	0.000845	0.00712	CcSEcCtD
Paroxetine—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.000842	0.00709	CcSEcCtD
Paroxetine—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.000842	0.00709	CcSEcCtD
Paroxetine—Gastritis—Ramipril—type 1 diabetes mellitus	0.000828	0.00697	CcSEcCtD
Paroxetine—CHRM3—kidney—type 1 diabetes mellitus	0.000812	0.0181	CbGeAlD
Paroxetine—Dysphagia—Ramipril—type 1 diabetes mellitus	0.000809	0.00681	CcSEcCtD
Paroxetine—Influenza—Ramipril—type 1 diabetes mellitus	0.000809	0.00681	CcSEcCtD
Paroxetine—Asthma—Ramipril—type 1 diabetes mellitus	0.000809	0.00681	CcSEcCtD
Paroxetine—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.000801	0.00674	CcSEcCtD
Paroxetine—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.000793	0.00668	CcSEcCtD
Paroxetine—Sweating increased—Ramipril—type 1 diabetes mellitus	0.000788	0.00663	CcSEcCtD
Paroxetine—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.000788	0.00663	CcSEcCtD
Paroxetine—Bronchitis—Ramipril—type 1 diabetes mellitus	0.000778	0.00655	CcSEcCtD
Paroxetine—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.000768	0.00647	CcSEcCtD
Paroxetine—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.000745	0.00627	CcSEcCtD
Paroxetine—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000738	0.00622	CcSEcCtD
Paroxetine—Weight increased—Ramipril—type 1 diabetes mellitus	0.000736	0.0062	CcSEcCtD
Paroxetine—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.000715	0.00602	CcSEcCtD
Paroxetine—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.000711	0.00599	CcSEcCtD
Paroxetine—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.000707	0.00595	CcSEcCtD
Paroxetine—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.000707	0.00595	CcSEcCtD
Paroxetine—Jaundice—Ramipril—type 1 diabetes mellitus	0.000703	0.00592	CcSEcCtD
Paroxetine—Stomatitis—Ramipril—type 1 diabetes mellitus	0.000703	0.00592	CcSEcCtD
Paroxetine—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.000701	0.0059	CcSEcCtD
Paroxetine—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.000701	0.0059	CcSEcCtD
Paroxetine—Sweating—Ramipril—type 1 diabetes mellitus	0.000691	0.00582	CcSEcCtD
Paroxetine—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000682	0.00574	CcSEcCtD
Paroxetine—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00068	0.00573	CcSEcCtD
Paroxetine—Sinusitis—Ramipril—type 1 diabetes mellitus	0.000676	0.0057	CcSEcCtD
Paroxetine—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000673	0.00567	CcSEcCtD
Paroxetine—CYP2B6—nephron tubule—type 1 diabetes mellitus	0.000672	0.015	CbGeAlD
Paroxetine—CYP2C8—kidney—type 1 diabetes mellitus	0.000658	0.0147	CbGeAlD
Paroxetine—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000647	0.00545	CcSEcCtD
Paroxetine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000638	0.00537	CcSEcCtD
Paroxetine—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000636	0.00536	CcSEcCtD
Paroxetine—Visual impairment—Ramipril—type 1 diabetes mellitus	0.000624	0.00525	CcSEcCtD
Paroxetine—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000612	0.00515	CcSEcCtD
Paroxetine—CYP2B6—cardiovascular system—type 1 diabetes mellitus	0.000604	0.0135	CbGeAlD
Paroxetine—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000603	0.00508	CcSEcCtD
Paroxetine—Flushing—Ramipril—type 1 diabetes mellitus	0.000601	0.00506	CcSEcCtD
Paroxetine—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000598	0.0133	CbGeAlD
Paroxetine—CYP2B6—kidney—type 1 diabetes mellitus	0.000591	0.0132	CbGeAlD
Paroxetine—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000585	0.00492	CcSEcCtD
Paroxetine—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000583	0.00491	CcSEcCtD
Paroxetine—HTR2A—retina—type 1 diabetes mellitus	0.000582	0.013	CbGeAlD
Paroxetine—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.000578	0.00487	CcSEcCtD
Paroxetine—Alopecia—Ramipril—type 1 diabetes mellitus	0.000572	0.00482	CcSEcCtD
Paroxetine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000567	0.00478	CcSEcCtD
Paroxetine—Erythema—Ramipril—type 1 diabetes mellitus	0.000563	0.00474	CcSEcCtD
Paroxetine—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000563	0.00474	CcSEcCtD
Paroxetine—Tension—Ramipril—type 1 diabetes mellitus	0.000553	0.00466	CcSEcCtD
Paroxetine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000552	0.00465	CcSEcCtD
Paroxetine—Nervousness—Ramipril—type 1 diabetes mellitus	0.000547	0.00461	CcSEcCtD
Paroxetine—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000542	0.00456	CcSEcCtD
Paroxetine—Tremor—Ramipril—type 1 diabetes mellitus	0.000528	0.00445	CcSEcCtD
Paroxetine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000523	0.0044	CcSEcCtD
Paroxetine—Agitation—Ramipril—type 1 diabetes mellitus	0.000518	0.00436	CcSEcCtD
Paroxetine—Angioedema—Ramipril—type 1 diabetes mellitus	0.000515	0.00434	CcSEcCtD
Paroxetine—Malaise—Ramipril—type 1 diabetes mellitus	0.000508	0.00428	CcSEcCtD
Paroxetine—CYP2B6—lymphoid tissue—type 1 diabetes mellitus	0.000507	0.0113	CbGeAlD
Paroxetine—Vertigo—Ramipril—type 1 diabetes mellitus	0.000506	0.00426	CcSEcCtD
Paroxetine—Syncope—Ramipril—type 1 diabetes mellitus	0.000505	0.00425	CcSEcCtD
Paroxetine—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000504	0.00425	CcSEcCtD
Paroxetine—Palpitations—Ramipril—type 1 diabetes mellitus	0.000498	0.00419	CcSEcCtD
Paroxetine—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000495	0.00417	CcSEcCtD
Paroxetine—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.000492	0.011	CbGeAlD
Paroxetine—Cough—Ramipril—type 1 diabetes mellitus	0.000492	0.00414	CcSEcCtD
Paroxetine—Convulsion—Ramipril—type 1 diabetes mellitus	0.000488	0.00411	CcSEcCtD
Paroxetine—HTR2A—kidney—type 1 diabetes mellitus	0.000482	0.0107	CbGeAlD
Paroxetine—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00048	0.00404	CcSEcCtD
Paroxetine—Myalgia—Ramipril—type 1 diabetes mellitus	0.00048	0.00404	CcSEcCtD
Paroxetine—Chest pain—Ramipril—type 1 diabetes mellitus	0.00048	0.00404	CcSEcCtD
Paroxetine—Anxiety—Ramipril—type 1 diabetes mellitus	0.000478	0.00403	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000476	0.00401	CcSEcCtD
Paroxetine—Discomfort—Ramipril—type 1 diabetes mellitus	0.000474	0.00399	CcSEcCtD
Paroxetine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000469	0.00395	CcSEcCtD
Paroxetine—Confusional state—Ramipril—type 1 diabetes mellitus	0.000464	0.0039	CcSEcCtD
Paroxetine—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00046	0.00387	CcSEcCtD
Paroxetine—Oedema—Ramipril—type 1 diabetes mellitus	0.00046	0.00387	CcSEcCtD
Paroxetine—Shock—Ramipril—type 1 diabetes mellitus	0.000452	0.00381	CcSEcCtD
Paroxetine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000451	0.0038	CcSEcCtD
Paroxetine—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00045	0.00379	CcSEcCtD
Paroxetine—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000449	0.00378	CcSEcCtD
Paroxetine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000447	0.00376	CcSEcCtD
Paroxetine—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000446	0.00994	CbGeAlD
Paroxetine—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000444	0.00374	CcSEcCtD
Paroxetine—CYP2D6—kidney—type 1 diabetes mellitus	0.000439	0.00978	CbGeAlD
Paroxetine—Hypotension—Ramipril—type 1 diabetes mellitus	0.00043	0.00362	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000419	0.00353	CcSEcCtD
Paroxetine—Insomnia—Ramipril—type 1 diabetes mellitus	0.000416	0.0035	CcSEcCtD
Paroxetine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000413	0.00348	CcSEcCtD
Paroxetine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00041	0.00345	CcSEcCtD
Paroxetine—Somnolence—Ramipril—type 1 diabetes mellitus	0.000409	0.00344	CcSEcCtD
Paroxetine—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000405	0.00341	CcSEcCtD
Paroxetine—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.0004	0.00337	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000397	0.00334	CcSEcCtD
Paroxetine—Fatigue—Ramipril—type 1 diabetes mellitus	0.000396	0.00334	CcSEcCtD
Paroxetine—Constipation—Ramipril—type 1 diabetes mellitus	0.000393	0.00331	CcSEcCtD
Paroxetine—ABCB1—retina—type 1 diabetes mellitus	0.000381	0.0085	CbGeAlD
Paroxetine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000379	0.00319	CcSEcCtD
Paroxetine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000376	0.00317	CcSEcCtD
Paroxetine—Urticaria—Ramipril—type 1 diabetes mellitus	0.000365	0.00308	CcSEcCtD
Paroxetine—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000363	0.00306	CcSEcCtD
Paroxetine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000363	0.00306	CcSEcCtD
Paroxetine—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000359	0.00801	CbGeAlD
Paroxetine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000339	0.00285	CcSEcCtD
Paroxetine—Asthenia—Ramipril—type 1 diabetes mellitus	0.00033	0.00278	CcSEcCtD
Paroxetine—Pruritus—Ramipril—type 1 diabetes mellitus	0.000325	0.00274	CcSEcCtD
Paroxetine—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000323	0.00719	CbGeAlD
Paroxetine—ABCB1—kidney—type 1 diabetes mellitus	0.000316	0.00703	CbGeAlD
Paroxetine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000315	0.00265	CcSEcCtD
Paroxetine—ABCB1—pancreas—type 1 diabetes mellitus	0.000314	0.00699	CbGeAlD
Paroxetine—Dizziness—Ramipril—type 1 diabetes mellitus	0.000304	0.00256	CcSEcCtD
Paroxetine—Vomiting—Ramipril—type 1 diabetes mellitus	0.000292	0.00246	CcSEcCtD
Paroxetine—Rash—Ramipril—type 1 diabetes mellitus	0.00029	0.00244	CcSEcCtD
Paroxetine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00029	0.00244	CcSEcCtD
Paroxetine—Headache—Ramipril—type 1 diabetes mellitus	0.000288	0.00243	CcSEcCtD
Paroxetine—Nausea—Ramipril—type 1 diabetes mellitus	0.000273	0.0023	CcSEcCtD
Paroxetine—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000271	0.00604	CbGeAlD
Paroxetine—CHRM4—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.22e-05	0.000174	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.21e-05	0.000174	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.2e-05	0.000173	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	2.19e-05	0.000172	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.19e-05	0.000172	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.18e-05	0.000171	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.17e-05	0.00017	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.16e-05	0.00017	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL2—type 1 diabetes mellitus	2.16e-05	0.00017	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	2.16e-05	0.00017	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.16e-05	0.000169	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.15e-05	0.000169	CbGpPWpGaD
Paroxetine—TACR1—Signaling by GPCR—IL6—type 1 diabetes mellitus	2.15e-05	0.000169	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.14e-05	0.000168	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	2.13e-05	0.000167	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.13e-05	0.000167	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—VAV1—type 1 diabetes mellitus	2.13e-05	0.000167	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CXCL10—type 1 diabetes mellitus	2.12e-05	0.000166	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.12e-05	0.000166	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—HBA1—type 1 diabetes mellitus	2.11e-05	0.000166	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	2.1e-05	0.000165	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—APOC3—type 1 diabetes mellitus	2.1e-05	0.000165	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	2.08e-05	0.000163	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.07e-05	0.000162	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GSTT1—type 1 diabetes mellitus	2.06e-05	0.000162	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.06e-05	0.000162	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.06e-05	0.000161	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.06e-05	0.000161	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.05e-05	0.000161	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.05e-05	0.000161	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.05e-05	0.000161	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.04e-05	0.00016	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.04e-05	0.00016	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	2.03e-05	0.00016	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—APOC3—type 1 diabetes mellitus	2.02e-05	0.000159	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IAPP—type 1 diabetes mellitus	2.02e-05	0.000159	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—TYK2—type 1 diabetes mellitus	2.02e-05	0.000158	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IGF2—type 1 diabetes mellitus	2.01e-05	0.000158	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	1.98e-05	0.000156	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.97e-05	0.000155	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	1.96e-05	0.000154	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.96e-05	0.000154	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.95e-05	0.000153	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.94e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CD86—type 1 diabetes mellitus	1.94e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	1.93e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.93e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.93e-05	0.000152	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.92e-05	0.000151	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.92e-05	0.000151	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GCG—type 1 diabetes mellitus	1.91e-05	0.00015	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	1.91e-05	0.00015	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	1.9e-05	0.000149	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CD86—type 1 diabetes mellitus	1.85e-05	0.000146	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.85e-05	0.000145	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	1.85e-05	0.000145	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.84e-05	0.000144	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	1.83e-05	0.000144	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.82e-05	0.000143	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SST—type 1 diabetes mellitus	1.81e-05	0.000142	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.8e-05	0.000141	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SST—type 1 diabetes mellitus	1.8e-05	0.000141	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SST—type 1 diabetes mellitus	1.79e-05	0.000141	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.79e-05	0.00014	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	1.79e-05	0.00014	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.78e-05	0.00014	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	1.78e-05	0.000139	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SST—type 1 diabetes mellitus	1.77e-05	0.000139	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.77e-05	0.000139	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	1.77e-05	0.000139	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.76e-05	0.000138	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.75e-05	0.000137	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	1.74e-05	0.000137	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.72e-05	0.000135	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.69e-05	0.000133	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.68e-05	0.000132	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.67e-05	0.000131	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	1.65e-05	0.00013	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.65e-05	0.00013	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.64e-05	0.000129	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GCG—type 1 diabetes mellitus	1.64e-05	0.000129	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.62e-05	0.000127	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—CAT—type 1 diabetes mellitus	1.62e-05	0.000127	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—GCG—type 1 diabetes mellitus	1.61e-05	0.000126	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.61e-05	0.000126	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.61e-05	0.000126	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—GCG—type 1 diabetes mellitus	1.6e-05	0.000126	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—GCG—type 1 diabetes mellitus	1.6e-05	0.000125	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—GCG—type 1 diabetes mellitus	1.58e-05	0.000124	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	1.56e-05	0.000122	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	1.56e-05	0.000122	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.55e-05	0.000122	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	1.55e-05	0.000121	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	1.55e-05	0.000121	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.54e-05	0.000121	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.54e-05	0.000121	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	1.52e-05	0.000119	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	1.52e-05	0.000119	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.5e-05	0.000118	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.5e-05	0.000118	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.5e-05	0.000118	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.49e-05	0.000117	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.49e-05	0.000117	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.49e-05	0.000117	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—VAV1—type 1 diabetes mellitus	1.48e-05	0.000116	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	1.47e-05	0.000116	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	1.47e-05	0.000115	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	1.46e-05	0.000114	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	1.45e-05	0.000114	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	1.45e-05	0.000114	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	1.43e-05	0.000112	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	1.42e-05	0.000111	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CD80—type 1 diabetes mellitus	1.41e-05	0.000111	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	1.39e-05	0.000109	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CAT—type 1 diabetes mellitus	1.39e-05	0.000109	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.37e-05	0.000107	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.36e-05	0.000107	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.36e-05	0.000107	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.36e-05	0.000106	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.36e-05	0.000106	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CD80—type 1 diabetes mellitus	1.35e-05	0.000106	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.35e-05	0.000106	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	1.34e-05	0.000105	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IGF2—type 1 diabetes mellitus	1.34e-05	0.000105	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—INS—type 1 diabetes mellitus	1.33e-05	0.000105	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	1.33e-05	0.000105	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CD86—type 1 diabetes mellitus	1.31e-05	0.000103	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.31e-05	0.000103	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CD86—type 1 diabetes mellitus	1.31e-05	0.000102	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CD86—type 1 diabetes mellitus	1.3e-05	0.000102	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.29e-05	0.000101	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CD86—type 1 diabetes mellitus	1.29e-05	0.000101	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.28e-05	0.000101	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—INS—type 1 diabetes mellitus	1.28e-05	0.0001	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.27e-05	9.97e-05	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.25e-05	9.84e-05	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.25e-05	9.79e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.25e-05	9.78e-05	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.24e-05	9.76e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.24e-05	9.72e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IGF1—type 1 diabetes mellitus	1.24e-05	9.7e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.23e-05	9.69e-05	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	1.23e-05	9.66e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—EGFR—type 1 diabetes mellitus	1.23e-05	9.65e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—E2F1—type 1 diabetes mellitus	1.22e-05	9.6e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.21e-05	9.51e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.19e-05	9.36e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.18e-05	9.29e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.18e-05	9.24e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	1.18e-05	9.24e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.17e-05	9.21e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.17e-05	9.19e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.16e-05	9.14e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	1.16e-05	9.12e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.16e-05	9.09e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.15e-05	9.06e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.15e-05	9e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCR5—type 1 diabetes mellitus	1.14e-05	8.97e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TYK2—type 1 diabetes mellitus	1.14e-05	8.96e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	1.14e-05	8.96e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.14e-05	8.96e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.14e-05	8.94e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.14e-05	8.93e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.13e-05	8.89e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	1.13e-05	8.88e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.13e-05	8.86e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	1.13e-05	8.84e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NOS3—type 1 diabetes mellitus	1.12e-05	8.8e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL2—type 1 diabetes mellitus	1.12e-05	8.77e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—INS—type 1 diabetes mellitus	1.07e-05	8.42e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	1.03e-05	8.05e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.93e-06	7.8e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	9.92e-06	7.79e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.87e-06	7.75e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	9.83e-06	7.72e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	9.66e-06	7.58e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	9.58e-06	7.52e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	9.57e-06	7.51e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	9.52e-06	7.47e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.51e-06	7.47e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	9.5e-06	7.46e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	9.49e-06	7.45e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.45e-06	7.42e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	9.4e-06	7.38e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	9.4e-06	7.38e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—INS—type 1 diabetes mellitus	9.23e-06	7.24e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	9.04e-06	7.1e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	9e-06	7.06e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	8.97e-06	7.04e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	8.88e-06	6.97e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.75e-06	6.87e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.7e-06	6.83e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.7e-06	6.83e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.67e-06	6.81e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.66e-06	6.8e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.63e-06	6.78e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	8.59e-06	6.74e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	8.55e-06	6.71e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ALB—type 1 diabetes mellitus	8.46e-06	6.64e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	8.35e-06	6.55e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—NOS3—type 1 diabetes mellitus	8.09e-06	6.35e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.08e-06	6.34e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.04e-06	6.31e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	8.01e-06	6.29e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.99e-06	6.28e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.93e-06	6.23e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.93e-06	6.23e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.89e-06	6.19e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.86e-06	6.17e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	7.81e-06	6.13e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.79e-06	6.11e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.59e-06	5.96e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.26e-06	5.7e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	7.16e-06	5.62e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	6.85e-06	5.38e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—INS—type 1 diabetes mellitus	6.8e-06	5.34e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.73e-06	5.29e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	6.72e-06	5.28e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.7e-06	5.26e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.69e-06	5.25e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	6.69e-06	5.25e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.68e-06	5.24e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	6.67e-06	5.23e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.65e-06	5.22e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.63e-06	5.21e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	6.61e-06	5.19e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	6.6e-06	5.18e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	6.57e-06	5.16e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	6.41e-06	5.03e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	6.36e-06	4.99e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	6.24e-06	4.9e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	5.97e-06	4.69e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	5.88e-06	4.62e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	5.83e-06	4.58e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	5.83e-06	4.58e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.66e-06	4.44e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.63e-06	4.42e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	5.62e-06	4.41e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.61e-06	4.4e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	5.58e-06	4.38e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	5.57e-06	4.38e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.55e-06	4.36e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.14e-06	4.04e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.11e-06	4.02e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.1e-06	4e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.05e-06	3.96e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	3.95e-06	3.1e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	3.93e-06	3.09e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	3.92e-06	3.08e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.88e-06	3.05e-05	CbGpPWpGaD
